The revenue from operations jumped 43% YoY to ₹291 crore in Q2 FY25, compared to ₹203 crore in the same quarter of the previous year.

Hospital stocks have seen an uptick in prices as India reported 3 confirmed cases of HMPV. 2 of these cases have been ...

The Glass-Lined Equipment (GLE) industry is poised for significant growth, driven by multiple factors. GLE protects the ...

We have pieced together accounts from multiple reliable sources to build a picture of everyday life for Nasim and other women, who are currently being held in Evin prison. Many were among the tens ...

HBM Healthcare Investments AG / Key word (s): Quarter Results HBM Healthcare Investments reports a compelling 15 percent increase in NAV in the 2024 calendar year 03-Jan-2025 / 17:48 CET/CEST Release ...

Anthem Biosciences Limited, an innovation-driven and technology-focused contract research, development and manufacturing organization (CRDMO) with fully integrated operations spanning across drug ...

The IPO is entirely an OFS, the company will not receive any funds from the issue and the proceeds will go to the selling ...